Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect.
Valcz G, Patai AV, Kalmár A, Péterfia B, Fűri I, Wichmann B, Műzes G, Sipos F, Krenács T, Mihály E, Spisák S, Molnár B, Tulassay Z.
Valcz G, et al. Among authors: tulassay z.
PLoS One. 2014 Nov 18;9(11):e106143. doi: 10.1371/journal.pone.0106143. eCollection 2014.
PLoS One. 2014.
PMID: 25405986
Free PMC article.